Takara Bio Inc. TKBIF

Set alert

Price alert · TKBIF

All alert types
7.30 USD 0.00 0.00%

At close · Jul 2

7.30 Day range 23.20
5.00 52-week range 23.20
YTD
-68.53%
1 year
-68.53%
Open
23.20
Prev close
7.30
Mkt cap
879.03M
Vol
20
Avg vol
18
EPS
-0.53271
P/E
-13.70
More statistics
Low
7.30
High
23.20

5D chart

Chart tools
Interval

Chart is warming up

The five-day price history for TKBIF has not been loaded yet. Try again in a moment.

Valuation

P/E -14.6×
FY 2021: 17.2×FY 2022: 23.2×FY 2023: 286×FY 2024: 390×FY 2025: -14.6×
FY 2021 5y median 23.2× FY 2025
P/S 3.5×
FY 2021: 5.0×FY 2022: 4.7×FY 2023: 9.7×FY 2024: 9.0×FY 2025: 3.5×
FY 2021 5y median 5.0× FY 2025
P/B 1.3×
FY 2021: 3.6×FY 2022: 3.3×FY 2023: 3.8×FY 2024: 3.5×FY 2025: 1.3×
FY 2021 5y median 3.5× FY 2025
P/FCF -15.5×
FY 2021: -61.5×FY 2022: 11.9×FY 2023: -37.9×FY 2024: -91.6×FY 2025: -15.5×
FY 2021 5y median -37.9× FY 2025
EV/EBITDA 206×
FY 2021: 10.1×FY 2022: 12.3×FY 2023: 49.3×FY 2024: 58.1×FY 2025: 206×
FY 2021 5y median 49.3× FY 2025
EV/Sales 3.2×
FY 2021: 4.7×FY 2022: 4.1×FY 2023: 8.9×FY 2024: 8.4×FY 2025: 3.2×
FY 2021 5y median 4.7× FY 2025
FCF Yield -6.4%
FY 2021: -1.6%FY 2022: 8.4%FY 2023: -2.6%FY 2024: -1.1%FY 2025: -6.4%
FY 2021 5y median -1.6% FY 2025

Profitability

Gross Margin 50.3%
FY 2021: 72.7%FY 2022: 57.3%FY 2023: 61.9%FY 2024: 57.9%FY 2025: 50.3%
FY 2021 5y median 57.9% FY 2025
Operating Margin -11.6%
FY 2021: 42.7%FY 2022: 26.3%FY 2023: 6.9%FY 2024: 5.0%FY 2025: -11.6%
FY 2021 5y median 6.9% FY 2025
Net Margin -23.8%
FY 2021: 29.3%FY 2022: 20.5%FY 2023: 3.4%FY 2024: 2.3%FY 2025: -23.8%
FY 2021 5y median 3.4% FY 2025
ROE -9.3%
FY 2021: 20.7%FY 2022: 14.3%FY 2023: 1.3%FY 2024: 0.9%FY 2025: -9.3%
FY 2021 5y median 1.3% FY 2025
ROIC -3.7%
FY 2021: 21.2%FY 2022: 13.5%FY 2023: 1.4%FY 2024: 1.0%FY 2025: -3.7%
FY 2021 5y median 1.4% FY 2025
ROA -7.2%
FY 2021: 17.2%FY 2022: 12.4%FY 2023: 1.2%FY 2024: 0.8%FY 2025: -7.2%
FY 2021 5y median 1.2% FY 2025

Growth (YoY)

Revenue -18.0%
FY 2021: 0.0%FY 2022: 6.5%FY 2023: -51.4%FY 2024: 8.0%FY 2025: -18.0%
FY 2021 FY 2025
Operating Income -289.7%
FY 2021: 0.0%FY 2022: -34.4%FY 2023: -87.2%FY 2024: -21.4%FY 2025: -289.7%
FY 2021 FY 2025
EPS (diluted) -940.3%
FY 2021: 0.0%FY 2022: -25.9%FY 2023: -91.9%FY 2024: -26.6%FY 2025: -940.3%
FY 2021 FY 2025
Free Cash Flow -85.8%
FY 2021: 0.0%FY 2022: 615.3%FY 2023: -131.4%FY 2024: 58.6%FY 2025: -85.8%
FY 2021 FY 2025

Financial Health

Current Ratio 5.8×
FY 2021: 3.9×FY 2022: 5.4×FY 2023: 8.8×FY 2024: 8.1×FY 2025: 5.8×
FY 2021 5y median 5.8× FY 2025
Quick Ratio 4.3×
FY 2021: 2.5×FY 2022: 4.6×FY 2023: 7.1×FY 2024: 6.3×FY 2025: 4.3×
FY 2021 5y median 4.6× FY 2025
Debt / Equity 0.1×
FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.1×
FY 2021 5y median 0.0× FY 2025
Net Debt / EBITDA -15.0×
FY 2021: -0.7×FY 2022: -2.0×FY 2023: -4.4×FY 2024: -4.4×FY 2025: -15.0×
FY 2021 5y median -4.4× FY 2025
Interest Coverage -8.1×
FY 2021: 1257×FY 2022: 856×FY 2023: 131×FY 2024: 113×FY 2025: -8.1×
FY 2021 5y median 131× FY 2025

Dividends

Dividend Yield 1.5%
FY 2021: 0.6%FY 2022: 1.1%FY 2023: 1.2%FY 2024: 0.5%FY 2025: 1.5%
FY 2021 5y median 1.1% FY 2025
Payout Ratio -21.4%
FY 2021: 9.7%FY 2022: 24.8%FY 2023: 341.4%FY 2024: 196.7%FY 2025: -21.4%
FY 2021 5y median 24.8% FY 2025

Annual · latest fiscal year ends 2026-03-31